107 related articles for article (PubMed ID: 11574778)
1. Expression of p57/Kip2 protein in hepatocellular carcinoma.
Ito Y; Takeda T; Sakon M; Tsujimoto M; Monden M; Matsuura N
Oncology; 2001; 61(3):221-5. PubMed ID: 11574778
[TBL] [Abstract][Full Text] [Related]
2. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
4. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
5. Expression of p57/Kip2 protein in pancreatic adenocarcinoma.
Ito Y; Takeda T; Wakasa K; Tsujimoto M; Matsuura N
Pancreas; 2001 Oct; 23(3):246-50. PubMed ID: 11590319
[TBL] [Abstract][Full Text] [Related]
6. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma.
Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Monden M; Matsuura N
Liver; 2002 Apr; 22(2):145-9. PubMed ID: 12028409
[TBL] [Abstract][Full Text] [Related]
7. The role of cytoplasmic p57 in invasion of hepatocellular carcinoma.
Guo H; Li Y; Tian T; Han L; Ruan Z; Liang X; Wang W; Nan K
BMC Gastroenterol; 2015 Aug; 15():104. PubMed ID: 26271467
[TBL] [Abstract][Full Text] [Related]
8. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma.
Guo H; Lv Y; Tian T; Hu TH; Wang WJ; Sui X; Jiang L; Ruan ZP; Nan KJ
Carcinogenesis; 2011 Dec; 32(12):1897-904. PubMed ID: 22002319
[TBL] [Abstract][Full Text] [Related]
10. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 overexpression in hepatocellular carcinoma.
Joo M; Kang YK; Kim MR; Lee HK; Jang JJ
Liver; 2001 Apr; 21(2):89-95. PubMed ID: 11318977
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: an immunohistochemical study on 109 Italian patients.
D'Errico A; Grigioni WF; Fiorentino M; Baccarini P; Grazi GL; Mancini AM
Pathol Int; 1994 Sep; 44(9):682-7. PubMed ID: 7804430
[TBL] [Abstract][Full Text] [Related]
17. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.
Ito Y; Matsuura N; Sakon M; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Monden M
Br J Cancer; 1999 Oct; 81(4):747-51. PubMed ID: 10574266
[TBL] [Abstract][Full Text] [Related]
18. Linkage of elevated ets-2 expression to hepatocarcinogenesis.
Ito Y; Miyoshi E; Takeda T; Nagano H; Sakon M; Noda K; Tsujimoto M; Monden M; Matsuura N
Anticancer Res; 2002; 22(4):2385-9. PubMed ID: 12174931
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival.
Rosenberg E; Demopoulos RI; Zeleniuch-Jacquotte A; Yee H; Sorich J; Speyer JL; Newcomb EW
Hum Pathol; 2001 Aug; 32(8):808-13. PubMed ID: 11521224
[TBL] [Abstract][Full Text] [Related]
20. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]